John Rah advises pharmaceutical and medical device manufacturers, healthcare providers and suppliers and managed healthcare organizations on corporate compliance program development and operations designed to mitigate the risk of fraud and abuse. 

John counsels clients on investigations and informal inquiries by the US Department of Justice (DOJ) and the US Department of Health and Human Services Office of Inspector General (OIG). His work also includes conducting internal investigations for health care companies involving potential violations of relevant policies and procedures designed to ensure compliance with the anti-kickback, Food Drug and Cosmetics Act . 

John also has a deep background in negotiating and implementing Corporate Integrity Agreements (CIAs), Deferred Prosecution Agreements (DPAs), and state consent decrees, and regularly interacts with the OIG and other relevant agencies in connection with these integrity agreements.